Vimarsana
Biggest News Aggregation in the World

Page 18 - Human Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Trials Today - Breaking & Trending Today

Neuralink Is Now Recruiting Human Subjects - Vimarsana News

Neuralink Is Now Recruiting Human Subjects

Elon Musk's brain-computer interface company Neuralink is officially looking for test subjects for its upcoming human trials. The six-year trial, which the company is calling the PRIME Study (Precise Robotically Implanted Brain-Computer Interface), is aimed at folks with quadriplegia due to spinal cord injury or ALS, according to an official announcement, laying the groundwork for […]

Source: yahoo.com
neuralink: Elon Musk's Neuralink to start human trials for brain implant - Vimarsana News

neuralink: Elon Musk's Neuralink to start human trials for brain implant

Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday that it has received approval from an independent review board to start the first human trial of its brain implant for paralysis patients.

Neuralink begins recruitment for human trials - Vimarsana News

Neuralink begins recruitment for human trials

Neuralink, Elon Musk's brain chip company, is recruiting for human trials, according to a Sept. 19 post on X, formerly known as Twitter.

An Experimental Antibody Could Someday Make Organ Transplants Less of a Hassle - Vimarsana News

An Experimental Antibody Could Someday Make Organ Transplants Less of a Hassle

A lab-made antibody could one day make organ transplants less of an ordeal, recent research suggests. In experiments with nonhuman primates, the antibody appeared to be safe and effective at preventing the rejection of transplanted kidneys and pancreatic cells. Scientists hope that this treatment could reduce or even eliminate the need for lifelong anti-rejection drugs with certain kinds of transplants.

Source: yahoo.com
Elon Musk-backed Neuralink raises $280M - Vimarsana News

Elon Musk-backed Neuralink raises $280M

Elon Musk's Neuralink, a brain-computer interface company, has raised $280 million in Series D financing with Peter Thiel's Founders Fund leading the round. Syn